Abstract. Many environmental chemicals including pesticides have been reported to possess hormonal activities, and thus are classified as endocrine disruptors. Permethrin, a synthetic pyrethroid insecticide, is used worldwide, which provides potential environmental exposure. However, relatively few studies have reported on hormonal activities, particularly estrogenic and androgenic activities of permethrin, and the results of these studies are in some respects contradictory. Therefore, this study investigated the potential estrogenic and androgenic activities of permethrin in vitro and in vivo. We conducted an uterine Calbindin-D9k (CaBP-9k) gene expression assay and an uterotrophic assay for estrogenic activity, and a Hershberger assay for androgenic activity. The CaBP9k gene, one of the intracellular calcium binding proteins, is estrogen-responsive in the uterus. The rat uterotrophic and Hershberger assays are generally used as in vivo short-term screening assays for detecting the estrogenic and androgenic activities of chemicals, although these assays are still being validated by the Organization for Economic Cooperation and Development (OECD). Northern blot analysis showed the induction of uterine CaBP-9k mRNA level in response to permethrin as well as co-administration of permethrin with E2. In the uterotrophic assay using 18-day-old female rats, subcutaneous treatments with permethrin (10 to 800 mg/kg) for three days increased relative uterine wet weights, and E2-induced uterine weights. These effects were statistically significant at 800 and 200 mg/kg, respectively. Moreover, permethrin-induced uterine weights were inhibited by the coadministration of ICI 182,780, an antiestrogen. In the Hershberger assay, the administration of permethrin orally to testosterone propionate-treated castrated male rats led to statistically significant reductions in androgen-dependent sex accessory tissue (ventral prostate, seminal vesicles, levator ani and bulbocavernosus muscles, Cowper's gland and glans penis) weights at all doses tested (10, 50 and 100 mg/kg). These results suggest that permethrin might have estrogen-like effects on female rats, but antiandrogen-like effects on males.
. Of these insecticides, permethrin (3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid (3-phenoxyphenyl) methyl ester) is being increasingly used to protect domestic animals and the public, as well as agriculture from a variety of pests such as flies, fleas, mosquitoes, headlice, and mites, in both developed and developing countries [8] [9] [10] [11] [12] [13] [14] . Moreover, permethrin is registered as being suitable for application to clothing as an insect repellent to prevent West Nile virus in USA. These situations provide the p o t e n t i a l f o r e n v i r o n m e n t a l e x p o s u r e t o permethrin and its attendant human health risks. Many pesticides have been reported to possess estrogenic or androgenic activities [15] [16] [17] [18] [19] [20] [21] [22] , and thus are classified as endocrine disruptors. However, relatively few studies have reported on the estrogenic and androgenic activities of permethrin [3, [23] [24] [25] [26] , and the results of the studies are in some respects contradictory. Accordingly, more investigation is needed to clarify the estrogenic and androgenic activities of permethrin. The calbindin-D9k (CaBP-9k) gene is an intracellular calcium binding protein, which is present in a variety of cells, but which is mainly expressed in the intestine, lung and uterus. The CaBP-9k gene is dependent on vitamin-D in the intestine, whereas it is estrogen-responsive in the uterus [27] [28] [29] [30] . In non-pregnant rats, the CaBP-9k gene is present in the myometrium and in stromal cells of the uterus, but is not expressed in the immature rat uterus. Although this gene contains an imperfect estrogen responsive element (ERE) that differs by only one nucleotide from the vitallogenin consensus, it binds to the estrogen receptor [30] . The Organization for Economic Cooperation and Development (OECD) proposed a rodent uterotrophic assay and a Hershberger assay as in vivo short-term screening assays for detecting the estrogenic and androgenic properties of suspected endocrine disrupting chemicals in 2001, and both of these assays continue to be validated by the OECD. In the uterotrophic assay, the test protocols involve an immature rat uterotrophic assay, whereby chemicals are subcutaneously administered to immature female rats for three consecutive days. The Hershberger assay has been commonly used to determine the androgenic and antiandrogenic activities of certain chemicals [19, 20, 25, 31, 32] . In this study, we examined the potential estrogenic a c t i v i t y o f p e r m e t h r i n b y i m m a t u r e r a t uterotrophic assay, and the uterine CaBP-9k gene expression assay. Further, the Hershberger assay was used to determine the androgenic activity of permethrin.
Materials and Methods

Chemicals
Permethrin (CAS no:52645-53-1, 96.6% pure, mixture of cis (24.8%) and trans (71.8%) isomers) was obtained from Riedel-dehaën (Wunstorferasse, Germany). Details of the other chemicals used in this study and their purities are as follows. Corn oil, (Sigma, St. Louis, MO, USA); 17β-Estradiol (E2), CAS no. 50-28-2, 98.0% pure, (Sigma); ICI 182, 780, >99% pure, (TOCRIS, Bristol, UK); testosterone propionate (TP), CAS no. 57-85-2, ≥97.0% pure (Wako, Osaka, Japan); flutamide, CAS no. 33311-84-7 (Sigma, USA); and 4,4'-dichlorodiphenyldichloroethylene (p,p'-DDE), CAS no. 72-55-9, 99.9% pure (Sigma). Of these chemicals, E2 was used as an estrogen, and ICI 182, 780 as an antiestrogen in the uterotrophic assay, and TP and flutamide or p,p'-DDE were used as a reference androgen and antiandrogens, respectively.
Animals
In this study, we used Sprague-Dawley rats bred at our institute (National Institute of Toxicological Research, Korea Food and Drug Administration, Seoul, Korea. All animals used in this experiment were handled in an accredited Korean animal f a c i l i t y i n a c c o r d a n c e w i t h t h e A A A L A C International Animal Care policy (Accredited Unit, Korea Food and Drug Administration; Unit Number-000996). Animals were housed in polycarbonate cages under a strict light cycle (light on at 06:00 hours and off at 18:00 hours). In addition, all animals were given irradiated rodent chow diet (Biophia Inc., Gunpo, Korea) ad libitum, and were housed at 23 ± 2 C/RH 55 ± 5%.
Northern blot analysis of CaBP-9k mRNA
For the Northern blot analysis of CaBP-9k mRNA, uterine tissues obtained from uterotrophic assays were snap-frozen in liquid nitrogen. Three f r o z e n u t e r i p e r g r o u p w e r e i n d i v i d u a l l y homogenized, and total RNA was extracted using Trizol reagent (Life Technologies, Rockvill, MD, USA). RNAs were denatured by heating at 65 C for 1 5 m i n , a n d 1 0 m g o f t o t a l R N A w e r e electrophoresed in 1% agarose gel for 90 min at 110 V, and then transferred to a nylon membrane using a vacuum blotter. 18S rRNA was used as an indicator of total RNA quality.
Uterotrophic assay
The estrogenic activities of permethrin in vivo were examined by immature rat uterotrophic assays using 17β-estradiol (E2) as a positive control. Immature Sprague -Dawley female rats (18-daysold) were randomly assigned to the control and treatment groups. Permethrin (10 to 800 mg/kg), or permethrin (10 to 800 mg/kg) plus E2 (3 µg/kg), or ICI 182,780 (3 µg/kg) were administered to 19 to 21-day-old rats by subcutaneous injection. All chemicals were dissolved in 5 ml of corn oil before treatment. Animals were sacrificed by cervical dislocation 24 h after the final treatment. The uteri and vaginae were removed, trimmed free of fat, and weighed.
Hershberger assay
The Hershberger assay was performed according to the current draft guidelines of the rodent Hershberger assay (OECD, 2002). Sprague-Dawley male rats were castrated (removal of testis and epididymis via incision of the middle scrotum under ether anesthesia at 5 weeks old). To examine the androgenic activity of permethrin, it was administered daily (10, 50 or 100 mg/kg/day) to castrated rats by oral gavage for 10 days. As a reference androgen, 0.4 mg/kg of TP was injected once into the dorsal surface of castrated rats. To examine the antiandrogenic activity of permethrin, it was administered (10, 50 or 100 mg/kg/day) to TP-treated castrated rats by oral gavage for 10 days. Flutamide (25 mg/kg/day) and p,p'-DDE (100 m g / k g / d a y ) w e r e u s e d a s r e f e r e n c e antiandrogens. Animals were evaluated at least once daily for mortality, signs of injury and general appearance. Individual body weights and food consumption were determined at treatment start, and recorded once every three days until the last treatment during the administration period. Twenty-four hours after the final administration, five sex accessory tissues (ventral prostate; VP; s e m i n a l v e s i c l e , S V ; l e v a t o r a n i p l u s bulbocavernosus muscles, LABC; Cowper's gland, COW; and glans penis, GP) were excised, carefully trimmed of excess adhering tissue and fat, and weighed.
Statistical analysis
Experimental results are presented as means ± SEM. Experimental data were analyzed by one way analysis of variance (ANOVA), and multiple comparisons versus the control group were performed by Dunnett's Method using SigmaStat 2.03. In the uterotrophic assay, permethrin plus ICI 182 ,78 0-t reat ed grou ps we re compared to corresponding permethrin-treated groups. Significant differences between the groups were evaluated at p levels of 0.01 and 0.05.
Results
CaBP-9k mRNA expression
Northern blot analysis showed that CaBP-9k mRNA was up-regulated by permethrin, and that permethrin enhanced the E2-induced CaBP-9k mRNA level (Fig. 1) . A permethrin dose of 5 mg/ kg, the lowest dose, maximally induced CaBP-9k mRNA expression in response to permethrin, and co-administration of permethrin with E2. control, respectively. Subcutaneous treatment of permethrin (10 to 800 mg/kg) increased uterine wet weights, and enhanced E2-induced uterine wet weights at all doses tested (Fig. 2) . These effects were statistically significant, and showed maximal increases at permethrin doses of 800 and 200 mg/ kg respectively. To confirm the maximal increase in uterine weight by permethrin observed in this assay, permethrin was administered to immature female rats at up to 1,200 mg/kg, but no further increases in uterine weights were observed (data not shown). Increases in uterine weights by permethrin were inhibited by co-treatment with ICI 182, 780, an antiestrogen (Table 1) , confirming the estrogenic activity of permethrin. In addition, permethrin showed a tendency to increase vaginal wet weights, although this was not statistically significant (Table 2) . androgenic activity of permethrin. The results show that testosterone propionate (TP), a reference androgen induced significant increases in the absolute and relative weights of androgendependent sex accessory tissues (VP, SV, LABC, COW, and GP). In order of increasing potency these were ranked as SV (12) > VP (11) > COW (4.5) > L A B C ( 2 . 5 ) > G P ( 1 . 5 ) ; t h e n u m b e r s i n parentheses refer to fold increases compared to the control. These results indicate that of the androgen-dependent tissues tested, the seminal vesicle was most sensitive to androgen. On the other han d, perm ethrin did not affect th e androgen-dependent tissue weights at any dose tested, suggesting that it has no androgenic activity. In addition, TP showed no clinical signs, but did produce a statistically significant increase in food consumption, and an enhancement of body weight. Similarly, statistically significant increases in food consumption were observed in the p e r m e t h r i n -t r e a t e d g r o u p s d u r i n g t h e administration period (Table 4) . Data are presented as means ± SEM (N=8-12). * Significantly different from control, P < 0.01. 3) by p,p'-DDE; the numbers in parentheses refer to fold reductions compared to the TP-treated group. These results are in agreement with the Hershberger assay for androgenic activity. Thus, it seems that the seminal vesicle is the tissue most dependent on both androgen and antiandrogen. Likewise, the administration of permethrin to TPtreated castrated rats led to statistically significant reductions in the five sex accessory tissue weights at all doses tested (Figs. 3 and 4) , suggesting that permethrin has antiandrogenic activity.
Uterotrophic assay
Hershberger assay
Discussion
W e e x a m i n e d t h e e s t r o g e n i c a c t i v i t y o f permethrin by an immature rat uterotrophic assay and an uterine CaBP-9k mRNA expression assay. The androgenic activity of permethrin was also determined by the Hershberger assay. In the present study, permethrin was found to have e s t r o g e n -l i k e e f f e c t s o n f e m a l e r a t s , b u t antiandrogen-like effects on males. Our results are partially consistent with previous results of permethrin, but also differ in some respects. Our u t e r i n e C a B P -9 k m R N A e x p r e s s i o n a s s a y performed by Northern blot analysis showed the induction of uterine CaBP-9k mRNA expression in response to permethrin, and co-administration of permethrin with E2. Although several in vitro studies have been reported on the estrogenic or antiestrogenic potential of permethrin, results are inconsistent. Garey and Wolff reported that permethrin showed no statistically significant estrogen-antagonist activity in the Ishigawa Var-1 human endometrial cancer cell line or in the T47D human breast cancer cell line at 100 µM [23] .
However, Go et al. showed that permethrin (100 [34] . Zou et al. tested this possibility using an in vitro screening method to identify estrogenic compounds acting through a c-Neu mediated mechanism using some environmental chemicals such as Aroclor 1242, PCB 95, and cisand trans-permethrins [37] . They reported that the cis-and trans-isomers of permethrin showed a significant promoting effect on MCF-7 cell foci formation, and suggested that the estrogenic activity of permethrin might be mediated via the cNeu pathway. These results are in agreement with our findings in terms of the estrogenic activity of permethrin, but the action mechanism suggested by Zou et al. [37] differs from that suggested by our data, which indicates the involvement of an ERmediated pathway. In the present study, the uterotrophic assay showed that permethrin (10 to 800 mg/kg) increased uterine wet weights. But the uterine weights increased by permethrin were reduced by co-treatment with ICI 182,780, an antiestrogen, thus indicating the estrogenic activity of permethrin. Kunimatsu et al. assessed the estrogenic activity of permethrin using an uterotrophic assay, and reported the lack of an estrogenic effect for permethrin based on the absence of no increases in the weights of uteri [25] . I n t h i s u t e r o t r o p h i c a s s a y , 8 -w e e k -o l d ovariectomized Sprague-Dawley rats were used, and permethrin (37.5, 75 or 150 mg/kg/day) was administered by oral gavage for 3 days. The inconsistency between Kunimatsu's data and ours in terms of uterotrophic response appears to be due to differences in the animal models and treatment routes used. In the Hershberger assay for androgenic activity, testosterone propionate, a reference androgen induced significant increases in the absolute and relative weights of androgendependent tissues, and this increasing potency was ranked as SV>VP>COW>LABC>GP. In addition, in the Hershberger assay for antiandrogenic activity, flutamide and p,p'-DDE, reference antiandrogens, remarkably reduced the weights of sex accessory tissues, and in order of decreasing potency the effect was SV>VP>COW>LABC>GP by flutamide, and SV and VP>COW>LABC>GP by p,p'-DDE. These Hershberger assay results indicate that seminal vesicle tissue is most affected by both androgens and antiandrogens. In a similar fashion, the administration of permethrin to TPtreated castrated male rats by oral gavage for 10 days led to significant reductions in all of the androgen-dependent sex accessory tissue weights measured at all doses tested, and in order of d e c r e a s i n g p o t e n c y t h e e f f e c t w a s SV>VP>LABC>COW>GP. However, permethrin had no effect on the weights of sex accessory tissues when administered to castrated male rats without TP. These data indicate that permethrin has antiandrogenic activity, but it does not have androgenic activity. On the other hand, Kunimatsu et al. reported that permethrin has no androgenic and antiandrogenic effects in the Hershberger assay [25] . However, there are basic differences in assay protocols of the Hershberger assay used by Kunimatsu et al. [25] and the assay used in the present study. We performed the Hershberger assay according to the current draft guideline of the rodent Hershberger assay [35] , while Kunimatsu et al. used the 5-day Hershberger assay (EDSTAC, 1998). In addition, Tyler et al. reported that permethrin exhibited approximately 500-fold less antiandrogenic activity than flutamide in a human androgen receptor yeast screen assay [36] . Our results suggest that permethrin has estrogen-like effects on female rats, and antiandrogen-like effects on males, and therefore may affect the endocrine systems in rats.
